Thomas Colby, MD - Virginia Society for Pathology

advertisement
November 8, 2014
Omni Hotel
212 Ridge McIntire Rd, Charlottesville, VA 22903
434-817-6626
Please call Deana Nowell directly to book VSP blocked rooms.
This program is designed specifically for pathologists. You will learn to:
-Understand the current histologic criteria for the diagnosis of usual
interstitial pneumonia and idiopathic pulmonary fibrosis, and be
conversant with the radiologic findings of UIP/IPF.
-Be able to identify the histologic findings in a lung biopsy that might
suggest an underlying connective tissue disease-associated interstitial
pneumonia.
-Describe the benign histologic changes associated with smoking.
-Know the pitfalls and histologic features that are associated with
overdiagnosis, underdiagnosis, and misdiagnosis of lung cancer.
-Have a strategy for approaching the diagnosis of lung cancer in small
histologic specimens and those associated with relatively benign –
appearing/bland histologic features.
-Recognize the issues in the current morphologic diagnosis of non-small
cell lung cancer and understand how to optimize usage of histologic
material for treatment-related decisions.
-Summarize the key technical aspects of chromosomal microarray and
next generation sequencing
Determine when new genetic testing approaches are appropriate in
routine testing for both constitutional and neoplastic disorders Recognize the opportunities and challenges of current clinical
genetic/genomic testing
- Define the role of cytogenomics in current genetic testing strategies
-Identify the key cytogenomic markers in the diagnosis and prognosis of
MDS, AML, and plasma cell neoplasms
- Explain how chromosomal microarray can be used for diagnosis of
hematological disorders
- Discuss the role of next gen sequencing technology in classifying
hematological malignancies.
–Understand the normal and inflammatory cells of the epithelium and
mucosa of the gastrointestinal tract
-Understand and recognize the currently accepted definition of abnormal
numbers of eosinophils and lymphocytes and the currently accepted
hypothesis for the pathophysiology of eosinophilia and intraepithelial
lymphocytosis.
-Be able to describe the different symptoms, radiologic findings,
endoscopic findings, and pathologic findings in patients with eosinophilic
gastroenteritis and lymphocytic gastritis colitis and intraepithelial
lymphocytosis.
-Understand the clinical implications of eosinophilic gastroenteritis and
lymphocytic gastroenteritis.
-Understand common drug related reactions in the gastrointestinal tract
and the endoscopic and histologic appearances and the most common
differential diagnostic considerations.
-To review recent medicare changes regarding coding for
immunohistochemistry and molecular diagnostics.
–To review often miscoded claims in immunohistochemistry and
molecular diagnostics.
–To review methods to correctly code for work performed and avoid
fraud.
Speakers and Topics
REGISTRATION FORM
Thomas Colby, MD
Mayo Clinic
Update on Interstitial Lung Disease for the Pathologist
Difficulties in the Diagnosis of Lung Cancer –
Practical Aspects for the Practicing Pathologist
Please return this form with the appropriate fee
to the secretary at the address below.
NAME:________________________
(Please Print)
(Address if non-member)
Eli Williams, MD
University of Virginia
____I will attend Nov 8 Scientific Session
From Cytogenetics to Cytogenomics: Keeping
current in the molecular era
Molecular cytogenomics of hematological
malignancies
Theresa Emory, MD
Lymphocytes, Eosinophils, and Drug Induced Reactions in
the Gastrointestinal Tract
Elaine Jeter, MD
Medical Director –Molecular Diagnostics; Palmetto GBA
Update on Medicare Coding for Pathologists
Friday, November 7
Welcome Dinner and Presentation sponsored by Pfizer
“Update on Pulmonary Carcinoma Markers” (no CME), Time and
Location TBA (separate RSVP will be required)
Saturday, November 8
6:30 am
Board Meeting
7 -8 am
Registration & Breakfast
8-11:30
Morning Lectures
11:30-12:30
(3 CME)
Lunch – sponsored by Genentech
Update on Her-2 testing
(no CME)
12:30-1:15 pm
General Meeting
1:30-4:30
Afternoon Lectures (3 CME)
4:45-5:15 pm
Roundtable discussion
“What I wish I had learned as a resident”
5:30-6:30 -
Reception
____I will attend Reception
(Guest/_____)
MEETING FEES
$199.00 - Meeting fee for members in good
standing*
$299.00 - Meeting fee non-members, out-of-state
pathologists and other visitors.
No Fee—Residents, Fellows and Emeritus
*Dues must be current to receive CME credit.
You can sign up at www.vapath.org or
Mail form to:
Virginia Society for Pathology
c/o Teri Manley
698 Orangewood Dr.
Virginia Beach, VA 23453
Question?s:
virginiasocietyforpathology@gmail.com
(757) 498-8530
This activity has been planned and implemented in accordance with the
Essential Areas and Policies of the Accreditation Council for Continuing
Medical Education (ACCME) through the joint sponsorship of the College of
American Pathologists and Virginia Society for Pathology The College of
American Pathologists is accredited by the ACCME to provide continuing
medical education for physicians.
The College of American Pathologists designates this educational activity for
a maximum of _6_ AMA PRA Category 1 Credit(s)™. Physicians should only
claim credit commensurate with the extent of their participation in the
activity.
The content of this CME activity does not necessarily reflect the view or
policies of the College of American Pathologists
Download